Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Absci (ABSI) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Absci (ABSI) over the last 6 years, with Q3 2025 value amounting to $9.5 million.

  • Absci's Cash & Equivalents fell 7519.05% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year decrease of 7519.05%. This contributed to the annual value of $41.2 million for FY2024, which is 4304.61% down from last year.
  • As of Q3 2025, Absci's Cash & Equivalents stood at $9.5 million, which was down 7519.05% from $38.0 million recorded in Q2 2025.
  • Absci's Cash & Equivalents' 5-year high stood at $279.3 million during Q3 2021, with a 5-year trough of $9.5 million in Q3 2025.
  • For the 5-year period, Absci's Cash & Equivalents averaged around $95.6 million, with its median value being $60.5 million (2022).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 9495.19% in 2023, then surged by 41565.43% in 2024.
  • Quarter analysis of 5 years shows Absci's Cash & Equivalents stood at $252.6 million in 2021, then crashed by 76.26% to $60.0 million in 2022, then increased by 20.69% to $72.4 million in 2023, then plummeted by 43.05% to $41.2 million in 2024, then plummeted by 77.01% to $9.5 million in 2025.
  • Its Cash & Equivalents stands at $9.5 million for Q3 2025, versus $38.0 million for Q2 2025 and $47.0 million for Q1 2025.